In the specialized field of biochemical inquiry, researchers frequently distinguish between signaling proteins and synthetic laboratory compounds. When navig CXCL10/IP-10 in infectious diseases pathogenesis and - PMC ating the literature, one often encounters the IP-10 peptide, scientific Ipamorelin (10mg) ally recognized as CXCL10 (Interferon-gamma-induced protein 10 kDa). It is vital for investigators to maintain clarity between this native chemokine and other research-grade materials like Ipamorelin (10mg), often discussed in the context of growth hormone secretagogue studies.
Understanding the IP-10 (CXCL10) Signaling Protein
IP-10/CXCL10 is a critical 8.7 kDa protein belonging to the CXC chemokine family. My experience reviewing laboratory data suggests that its primary biological relevance lies in its role as a chemokine secreted in response to IFN-γ, playing a major role in the activation and regulation of inflammatory and immune responses within the body.
From an entity-focused perspective, the IP-10 (CXCL10)-derived peptide has been a subject of significant interest due to its angiostatic properties. Research indicates that this specific derivative inhibits endothe IP-10 lial cell function, modulating angiogenesis—a process critical for organ development and wound healing. It is well-documented that IP-10 signals through the CXCR3 receptor, which facilitates the selective attraction of T-lympho An IP-10 (CXCL10)-derived peptide inhibits angiogenesis cytes and monocytes. This mechanism is why IP-10 is seen in many Th1-type human inflammatory diseases, and why it is frequently studied as Expression of IP-10 is seen in many Th1-type human inflammatory diseases, including skin diseases (e.g., psoriasis), multiple sclerosis, atherosclerosis, a biomarker for cellular immune activation.
Distinguishing Research Compounds: Ipamorelin vs. IP-10
A common point of confusion in search queries involves the conflation of IP-10 and Ipamorelin. While their abbreviations may appear similar, they serve entirely different purposes in a laboratory setting:
* IP-10/CXCL10: A cytokine produced by monocytes, fibroblasts, and endothelial cells in response to IFNg and LPS. It is an important factor in autoimmune diseases, including Hashimoto’s thyroiditis and Type 1 diabetes mellitus.
* Ipamorelin (10mg): A synthetic pentapeptide growth hormone secretagogue. Unlike the inflammatory chemokine CXCL10, Ipamorelin is investigated for its selective interaction with the ghrelin/growth hormone secretagogue receptor (GHS-R1a) to st IP-10 is an important factor in autoimmune diseases such as Hashimoto's thyroiditis, Graves' disease, and Type 1 diabetes mellitus. Product images on the udy endocrine signaling pathways.
When sourcing Ipamorelin research peptide, investigators typically look for high-purity (99%+) compounds, often referred to in shorthand as CP10 (frequently a blend of CJC-1295 and Ipamorelin). These materials are intended exclusively for in-vitro or analytical laboratory research.
Analytical Considerations for Researchers
For those conducting experiments, the distinction betwee by S Madhurantakam · 2023 · Cited by 76 — IP-10 is a chemokine secreted in response to IFN-γ playing a major role in the activation and regulation of inflammatory and immune responses within the body. n IP-10 (Interferon-gamma inducible Protein 10kDa) and synthetic peptides is paramount. IP-10/CXCL10 protein function is highly specific to immune modulation, whereas Ipamorelin is a synthetic peptide used in laboratory research to explore growth hormone secretagogue mechanisms.
When reviewing data, always verify the source and the specific CAS number (such as 170851-70-4 for Ipamorelin). Whether you are focusing on the CXCL10 pathway in THP1-Blue KI-IP10 cells or evaluating the efficacy of a specialized Ipamorelin peptide batch, maintaining rigorous standards for purity and documentation ensures the integrity of your research workflow.
By keeping these entities distinct—recognizing IP-10 as a member of the CXC family of chemokines involved in immune regulation and Ipamorelin as a growth hormone-releasing peptide—researchers can better navigate the complex landscape of biochemical signaling and synthetic compound application.